← Leaderboards
Ping Yang
Mayo Clinic Coll Of Medicine, Rochester
$15,335,745
Attributed
$19,329,550
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,329,550 · 7
By mechanism
R01$14,582,434 · 5
U24$3,274,448 · 1
P50$1,472,668 · 1
Top collaborators
- Hua Xu6 shared
- Jeremy Lyle Warner5 shared
- Chris H Wendt4 shared
- Li Liu3 shared
- Joshua C. Denny1 shared
- Cui Tao1 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- David I Smith$1,089,673
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMalignant NeoplasmsDiagnosisBaseClinical ResearchCancer RiskPhenotypeMalignant Neoplasm Of LungCancer PatientClinicPathway InteractionsLungTumorResearch PersonnelGenomicsTissuesResponseRecurrenceReportingInvestigationStagingCharacteristicsPerformanceLearning
Grant awards (45)
Discover and Analyze Germline-Somatic Interactions in Cancer$333,404
R01 · FY2023 · LM
Discover and Analyze Germline-Somatic Interactions in Cancer$334,235
R01 · FY2022 · LM
Discover and Analyze Germline-Somatic Interactions in Cancer$349,256
R01 · FY2021 · LM
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$618,291
U24 · FY2020 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$600,683
U24 · FY2019 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$620,106
U24 · FY2018 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$79,500
U24 · FY2018 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$79,500
U24 · FY2018 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$623,596
U24 · FY2017 · CA
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics$652,772
U24 · FY2016 · CA
Common Pathogenetic Mechanisms of Lung Cancer and COPD$697,882
R01 · FY2014 · HL
Common Pathogenetic Mechanisms of Lung Cancer and COPD$668,065
R01 · FY2013 · HL
Common Pathogenetic Mechanisms of Lung Cancer and COPD$726,338
R01 · FY2012 · HL
Genetic Determinants of Lung Cancer Survival$227,213
R01 · FY2012 · CA · contact PI
Common Pathogenetic Mechanisms of Lung Cancer and COPD$718,596
R01 · FY2011 · HL
Genetic Determinants of Lung Cancer Survival$279,774
R01 · FY2011 · CA · contact PI
Health and QOL among Long-Term Lung Cancer Survivors$481,385
R01 · FY2010 · CA · contact PI
Genetic Determinants of Lung Cancer Survival$316,444
R01 · FY2010 · CA · contact PI
Health and QOL among Long-Term Lung Cancer Survivors$484,323
R01 · FY2009 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$451,218
R01 · FY2009 · CA · contact PI
Genetic Determinants of Lung Cancer Survival$366,188
R01 · FY2009 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$99,602
R01 · FY2009 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$524,374
R01 · FY2008 · CA · contact PI
Health and QOL among Long-Term Lung Cancer Survivors$494,114
R01 · FY2008 · CA · contact PI
Chromosome 19 q-arm Polymorphism and Glioma Development$393,151
P50 · FY2008 · CA · contact PI
Genetic Determinants of Lung Cancer Survival$339,822
R01 · FY2008 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$524,983
R01 · FY2007 · CA · contact PI
Health and QOL among Long-Term Lung Cancer Survivors$481,676
R01 · FY2007 · CA · contact PI
Chromosome 19 q-arm Polymorphism and Glioma Development$417,401
P50 · FY2007 · CA · contact PI
Genetic Determinants of Lung Cancer Survival$350,599
R01 · FY2007 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$466,357
R01 · FY2006 · CA · contact PI
Health and QOL among Long-Term Lung Cancer Survivors$451,712
R01 · FY2006 · CA · contact PI
Chromosome 19 q-arm Polymorphism and Glioma Development$183,628
P50 · FY2006 · CA · contact PI
Alpha-1 AD Carriers and Lung Cancer Risk$487,824
R01 · FY2005 · CA
Genetic Determinants of Lung Cancer Survival$336,137
R01 · FY2005 · CA
Chromosome 19 q-arm Polymorphism and Glioma Development$193,136
P50 · FY2005 · CA
Genetic Determinants of Lung Cancer Survival$419,532
R01 · FY2004 · CA
Chromosome 19 q-arm Polymorphism and Glioma Development$285,352
P50 · FY2004 · CA
Genetic Determinants of Lung Cancer Survival$451,465
R01 · FY2003 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK$311,284
R01 · FY2003 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK$523,787
R01 · FY2002 · CA
Genetic Determinants of Lung Cancer Survival$451,791
R01 · FY2002 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK$499,786
R01 · FY2001 · CA
Genetic Determinants of Lung Cancer Survival$429,863
R01 · FY2001 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK$503,405
R01 · FY2000 · CA